Frazier Life Sciences VIII, L.P.

Frazier Life Sciences VIII, L.P. has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Arcutis Biotherapeutics, Inc. and Alpine Immune Sciences, Inc. Between 10 May 2021 and 24 October 2023, the trades on record add up to 5 filings.

On the market, this insider has only ever bought: 3 purchases, €5.8M in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2023 to date brings 1 purchase and no sales.

Half of the purchases are above €701k and half below. Across 3 purchases, this insider has always bought alone, with no colleague buying within 30 days.

The newest entry dates from 26 October 2023: an open-market purchase of €189k, in Arcutis Biotherapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.